Study: NOPRODRPG0002
Protocol Name: Global Registry of Inherited Retinal Diseases (IRD registry)
Principal Investigator: Dr Fred Chen
ClinicalTrials.gov Identifier: NCT05957276
This study aims to create a registry of inherited retinal diseases. Once on the registry the study aims to describe the clinical course of the disease in diagnosed patients. This study will characterise the patient population diagnosed with IRD and describe the patient pathway as determined by the study doctors (Fred Chen).
To be considered for the study, participants must be genetically diagnosed with one of the following inherited retinal diseases:
- XLRP (X-Linked retinitis pigmentosa)
- ACHM (Achromatopsia)
The study duration is around 8 years, the number of visits within that time will be based on the standard visit schedule for these conditions.
You may visit the Clinical Trial Registry at Study Details | Global Patient Registry of Inherited Retinal Diseases | ClinicalTrials.gov for more information regarding the Global Registry of Inherited Retinal Diseases (IRD registry).
To enquire further about this study, please contact the Clinical Trials Office on (08) 9381 0755, or email lionsvisiontrials@lei.org.au.
